- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Head and Neck Squamous Carcinoma in South Africa
Total 2016 results
-
Merck Sharp & Dohme LLCActive, not recruitingGastric Neoplasms | Gastroesophageal Junction AdenocarcinomaUnited States, Australia, Brazil, Chile, China, France, Germany, Guatemala, Ireland, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
-
Alliance for Clinical Trials in OncologyBristol-Myers Squibb; National Cancer Institute (NCI); Sanofi; Pfizer; Eastern Cooperative...Completed
-
Calithera Biosciences, IncTerminatedNon-Small Cell Lung Cancer | Non-squamous Non-small-cell Lung Cancer | Non-Squamous Non-Small Cell Neoplasm of Lung | KEAP1 Gene Mutation | NRF2 Gene Mutation | NFE2L2 Gene MutationUnited States
-
National Cancer Institute (NCI)Active, not recruitingGlioma | Hematopoietic and Lymphoid Cell Neoplasm | Melanoma | Lymphoma | Multiple Myeloma | Recurrent Ovarian Carcinoma | Breast Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Skin Carcinoma | Gastric Carcinoma | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory... and other conditionsUnited States, Puerto Rico, Guam
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | Gastric Cancer Third LineSpain, Italy, Australia, Korea, Republic of, Belgium, France, Poland, United States, Czechia, Germany
-
PeplinCompletedSuperficial Basal Cell CarcinomaAustralia
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldRecruitingMelanoma | Sarcoma | Kidney Cancer | Head and Neck Cancer | Glioblastoma | Bladder CancerUnited Kingdom
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Terminated
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedGastric Cancer | Esophageal Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedGastric Cancer | Esophageal CancerUnited States
-
Medical University of South CarolinaTerminatedNewly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-IIUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrial Mucinous Adenocarcinoma | Endometrial Mixed Adenocarcinoma | Endometrial...United States
-
Virginia Commonwealth UniversityActive, not recruitingBreast Cancer | Invasive Breast Carcinoma | Lobular Breast Carcinoma In Situ | Breast Adenocarcinoma | Node-positive Breast CancerUnited States
-
AbbVieCompletedNon-squamous Non-small Cell Lung CancerUnited States, Argentina, Australia, Canada, Czechia, Denmark, Finland, Germany, Hungary, Israel, Japan, Korea, Republic of, Netherlands, New Zealand, Russian Federation, South Africa, Spain, Taiwan, Turkey, United Kingdom
-
University of BirminghamAstraZeneca; Cancer Trials IrelandActive, not recruitingOropharyngeal CancerUnited Kingdom, Ireland
-
CelgeneCompletedSquamous Cell Carcinoma, Non-Small-Cell LungUnited States, Spain, Germany, Italy, United Kingdom
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedEsophageal CancerUnited States
-
SCRI Development Innovations, LLCAchieve Life SciencesCompletedNon Squamous Non Small Cell Lung CancerUnited States
-
Melanoma Institute AustraliaRecruitingSkin Cancer | Basal Cell Carcinoma | Invasive Carcinoma | Basal Cell Carcinoma of Skin, Site UnspecifiedAustralia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedEsophageal CancerUnited States
-
Eisai Inc.Merck Sharp & Dohme LLCCompletedThyroid CancerUnited States, Canada, Germany, Korea, Republic of, Spain, France, Australia, Belgium, Denmark, Israel, Italy, Poland, Romania, Russian Federation, Sweden, United Kingdom
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedHigh Grade Squamous Intraepithelial Neoplasia | Stage 0 Uterine Corpus CancerUnited States
-
Galderma R&DCompleted
-
Pfizer's Upjohn has merged with Mylan to form Viatris...TerminatedAdenomatous Polyposis ColiItaly, United States, Belgium, Spain, Puerto Rico, Sweden, Israel, Czechia, Hong Kong, Hungary, Slovakia, South Africa, Ukraine, United Kingdom
-
International Atomic Energy AgencyCompletedNon Small Cell Lung CancerChile, China, Croatia, Egypt, India, Malaysia, Malta, Morocco, Pakistan, Panama, Peru, South Africa, Tunisia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedGastric Cancer | Esophageal CancerUnited States, Canada
-
University of OklahomaActive, not recruitingMelanoma | Renal Cell Carcinoma | Nonsmall Cell Lung Cancer | Metastatic Solid Tumor | Gastrointestinal Cancer | Immune Checkpoint Inhibitors | Squamous Cell CarcinomaUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Medical University of South CarolinaBristol-Myers SquibbWithdrawnClear Cell Renal Cell Carcinoma | Metastatic Renal Cell CarcinomaUnited States
-
Lucid Diagnostics, Inc.RecruitingBarrett Esophagus | Esophageal Adenocarcinoma | Barrett's Esophagus Without Dysplasia | Barretts Esophagus With DysplasiaUnited States, Netherlands
-
National Cancer Institute (NCI)RecruitingPancreatic Acinar Cell Carcinoma | Pancreatic Adenosquamous Carcinoma | Pancreatic Squamous Cell Carcinoma | Resectable Pancreatic Acinar Cell Carcinoma | Resectable Pancreatic Adenocarcinoma | Resectable Pancreatic Adenosquamous Carcinoma | Resectable Pancreatic CarcinomaUnited States
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Singapore, Hong Kong, Canada
-
ExelixisIpsenActive, not recruitingDifferentiated Thyroid CancerHong Kong, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Croatia, Czechia, France, Germany, Hungary, Israel, Korea, Republic of, Mexico, Netherlands, Poland, Romania, Russian Federation, Spain, Taiwan, ... and more
-
Eisai Inc.CompletedThyroid CancerUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Denmark, France, Germany, Italy, Japan, Korea, Republic of, Poland, Portugal, Romania, Russian Federation, Spain, Sweden, Thailand, United Kingdom
-
Genentech, Inc.Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerPoland, Belgium, Spain, United States, Canada, South Africa, Russian Federation, Hong Kong, Taiwan, Japan, France, United Kingdom, Australia, Germany, Hungary, Korea, Republic of, Netherlands, Croatia, Serbia, Israel, Ukraine, Peru, Brazi... and more
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, France, Chile, Australia, Netherlands, Argentina, Austria, Canada, Czechia, Germany, Hungary, Ireland, Italy, Mexico, Norway, Peru, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; NCIC Clinical... and other collaboratorsCompletedLung CancerUnited States, South Africa
-
Australian and New Zealand Urogenital and Prostate...RecruitingRenal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Papillary Renal Cell Carcinoma Type 1 | Papillary Renal Cell Carcinoma Type 2 | Chromophobe Renal Cell Carcinoma | Xp11.2 Translocation-Related Renal Cell CarcinomaAustralia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedEsophageal CancerUnited States
-
Melanoma and Skin Cancer Trials LimitedRecruitingMetastatic Merkel Cell CarcinomaAustralia
-
Apollomics (Australia) Pty. Ltd.Novotech (Australia) Pty Limited; Apollomics Inc. (formerly CBT Pharmaceuticals...TerminatedRenal Cell Carcinoma | Hepatocellular CarcinomaAustralia, New Zealand
-
Rain Oncology IncTerminatedMelanoma | Sarcoma | Cervical Cancer | Testicular Germ Cell Tumor | Gastric Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Lung Adenocarcinoma | Solid Tumors | Pancreas Cancer | Head and Neck Carcinoma | Biliary Tract Cancer | Ovarian Carcinoma | Adrenocortical Carcinoma | Bladder Urothelial Carcinoma | Breast... and other conditionsUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingClinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Unresectable Gastroesophageal Junction Adenocarcinoma | Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma... and other conditionsUnited States
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruiting
-
AbbVieCompletedSquamous Non-Small Cell Lung CancerUnited States, Australia, Austria, Belarus, Brazil, Canada, Croatia, Czechia, Denmark, Egypt, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Norway, Poland, P... and more
-
Medical University of South CarolinaCompletedHepatic Carcinoma | Chemoembolizaton | Transarterial EmbolizationUnited States
-
Bristol-Myers SquibbCompletedNon-Squamous Cell Non-small Cell Lung CancerUnited States, Germany, Hong Kong, Spain, Australia, Mexico, Austria, France, Singapore, Switzerland, Canada, Poland, Argentina, Brazil, Chile, Czechia, Hungary, Italy, Norway, Peru, Romania, Russian Federation
-
National Cancer Institute (NCI)Active, not recruitingLung Adenocarcinoma | Lung Large Cell Carcinoma | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Minimally Invasive Lung Adenocarcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Lung Squamous Cell Carcinoma | Lung Adenosquamous CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedRenal Cell CarcinomaSouth Africa, Egypt, Saudi Arabia, Russian Federation, Lebanon, Thailand, Jordan, India, Tunisia, Algeria